UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000035622
Receipt No. R000040516
Scientific Title A Multicenter Phase II study of Trastuzumab emtansine for non-small cell lung cancer positive for HER2 exon 20 insertion mutation.
Date of disclosure of the study information 2019/01/22
Last modified on 2019/05/29 10:28:08

No. Disposal Last modified on Item of update
1 Insert 2019/01/22 15:52:06
2 Update 2019/02/06 15:25:44 Institutions
3 Update 2019/02/08 11:30:31 Institutions
4 Update 2019/02/28 11:12:25 Recruitment status
5 Update 2019/04/01 14:32:47 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
Institutions
6 Update 2019/05/10 13:57:14 Institutions
7 Update 2019/05/29 10:28:08 Institutions


Contact us.